GMTX
Gemini Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
IPO Date
2020-08-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Gemini Therapeutics, Inc.
IPO Date
2020-08-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 30,000 |
| $64.00 |
| 12 Jan 2024 | Atlas Venture Fund X, L.P. | 10 percent owner | S-Sale | Disposed | 20,000 | $64.00 |
| 3 Jan 2024 | Quisel John D | director, officer: Chief Executive Officer | M-Exempt | Disposed | 2,700 | $1.01 |
| 3 Jan 2024 | Quisel John D | director, officer: Chief Executive Officer | M-Exempt | Acquired | 2,700 | $1.01 |
| 20 Dec 2023 | Ashiya Mona | director | M-Exempt | Acquired | 1,724 | $38.00 |
| 20 Dec 2023 | Ashiya Mona | director | M-Exempt | Disposed | 1,724 | $38.00 |
| 20 Dec 2023 | Ashiya Mona | director | S-Sale | Disposed | 1,724 | $59.24 |
| 20 Dec 2023 | ORBIMED ADVISORS LLC | director | M-Exempt | Acquired | 1,724 | $38.00 |
| 20 Dec 2023 | ORBIMED ADVISORS LLC | director | S-Sale | Disposed | 1,724 | $59.24 |